Brief: Medpace Holdings Inc Reports Second Quarter 2023 Results
July 24 (Reuters) - Medpace Holdings Inc MEDP.O :
* MEDPACE HOLDINGS, INC. REPORTS SECOND QUARTER 2023 RESULTS
* MEDPACE HOLDINGS INC - FORECASTS 2023 REVENUE IN RANGE OF
$1.840
BILLION TO $1.880 BILLION
* MEDPACE HOLDINGS INC - FULL YEAR 2023 EBITDA IS EXPECTED
IN
RANGE OF $340.0 MILLION TO $358.0 MILLION
* MEDPACE HOLDINGS INC - FY DILUTED EARNINGS PER SHARE GAAP
IS
FORECASTED IN RANGE OF $8.04 TO $8.50.
Source text for Eikon: ID:nBwbx7Hlwa
Further company coverage: MEDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medpace Holdings
See all newsBrief: Medpace Holdings, Inc. To Report Second Quarter 2026 Financial Results On July 22, 2026
U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems
Brief: Medpace Holdings Inc Forecasts 2026 Revenue $2.755 Billion-$2.855 Billion, Up 8.9%-12.8%
Medpace Q1 revenue beats analyst estimates
Brief: Medpace Q1 Revenue USD 706.604 Million Vs. IBES Estimate USD 697.7 Million